Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

JHS Svendgaard Laboratories Ltd Performance

Today's Low
16.35
arrowIcon
Today's High
16.65
52 Wk Low
15.55
arrowIcon
52 Wk High
39.50


Open

16.35

Traded Value (Cr)

10.05 L

Prev. Close

16.65

VWAP

16.38

Volume

17,086

Face Value

10

JHS Svendgaard Laboratories Ltd Fundamentals

Market Cap
₹ 138 Cr
P/E Ratio (TTM)
25.94
P/B Ratio
0.81
Debt to Equity
0.01
ROE
1.49 %
EPS (TTM)
0.68
Dividend Yield
0.00%
Book Value
21.79

Click here to know more about Fundamentals

JHS Svendgaard Laboratories Ltd Financials

JHS Svendgaard Laboratories Ltd Financials

JHS Svendgaard Laboratories Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 42.75 % 40.04 % 39.86 % 46.36 %
Promoters 37.73 % 37.73 % 37.73 % 42.23 %
Others 17.22 % 22.22 % 22.41 % 11.41 %
FII 2.30 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Retail

42.75%

Promoters

37.73%

Others

17.22%

FII

2.30%

Mutual Funds

0.00%

Retail

40.04%

Promoters

37.73%

Others

22.22%

FII

0.00%

Mutual Funds

0.00%

Retail

39.86%

Promoters

37.73%

Others

22.41%

FII

0.00%

Mutual Funds

0.00%

Retail

46.36%

Promoters

42.23%

Others

11.41%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹17.30

PIVOT

resistance-arrow
Resistance
First Resistance₹17.300
Second Resistance₹17.300
Third Resistance₹17.300
support-arrow
Support
First Resistance₹17.300
Second Resistance₹17.300
Third Resistance₹17.300
RSI38.461
MACD-0.311
ADX19.908
CCI-158.477

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day17,08617,086100.00
Week33,24937,888100.00
1 Month44,41045,244100.00
6 Months40,97040,970100.00

About JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd. is India's largest integrated manufacturer of oral care products that services the demanding requirements of leading Indian and global FMCG brands operating in Indian. Apart from contract manufacturing partnerships with domestic oral care brands, the Company manufactures proprietary brands as well. The Company manufactures the entire range of oral care product at its ISO-certified state of-the-art manufacturing facilities at Kala Amb (Himachal Pradesh). The Company is into manufacturing toothpaste, toothbrushes, mouth rinse etc. The company's products include toothbrushes, toothpaste, whitening gel, whitening mouth rinse and denture cleaning effervescent tablet. JHS Svendgaard Laboratories Ltd was incorporated on October 8, 2004. The company was established to engage in the business of manufacturing and selling of oral hygiene products. The company was promoted by Nikhil Nanda. Initially, they manufactured only toothbrushes but realizing the vast potential of the oral care market, they ventured into manufacturing of other dental care products like toothpastes, Mouthwash, Denture tablets etc. In the year 2005, the company acquired the business from the three proprietary concerns namely Sunehari Svendgaard Laboratories, Sunehari Oral Care and Jai Hanuman Exports with effect from April 1, 2005. These three proprietary concerns became the three units of the company, namely Unit I- SSL, Unit II - SOC and Unit III - JHE. In the year 2006, Unit III-JHE was awarded the status of Star Export House (one Star) by the Government of India effective from April 1, 2005 to March 31, 2009. During the year 2006-07, the company increased the production capacity of Oral Care Products by 1.50 crore Pcs to 7.00 crore Pcs. In October 21, 2006, the company shares were listed on the Bombay Stock Exchange Ltd and the National Stock Exchange of India Ltd. In April 2, 2007, the company commenced the first phase of commercial Production at Kala-amb in Himachal Pradesh. In April 10, 2007, they acquired 9400 equity shares of Rs 10 each of Nikiven Personal Care Products Pvt Ltd {NIKIVEN} constituting 51.08% of the paid-up capital. With this acquisition, Nikiven became a subsidiary of the company. During the year 2007-08, the company set up a 100% subsidiary company in Ras Al Khaimah Free Trade Zone, UAE with the name of Jones H Smith, FZE. In April 2008, they set up a subsidiary company with the name JHS Svendgaard Dental Care Ltd. During the year 2008-09, the company increased the production capacity of Oral Care Products by 13.02 crore Pcs to 24.62 crore Pcs. In February 4, 2009, they received the Best Performing Enterprise Award 'Runner-up' (Turnover from Rs 26 to 100 crore) at Plasticon Awards 2009 for the oral care business with a Complete Range of Oral Care Products from The Plastindia Foundation. In April 2009, the company launched their own brand 'Dr. Gold', to use their experience in the oral care industry and encash the market opportunities. The Scheme of Amalgamation of M/s JHS Svendgaard Hygiene Products Limited and M/s Waves Hygiene Products (a Partnership Firm) with M/s JHS Svendgaard Laboratories had been approved by the Delhi High Court on 30th August, 2011 and by the Shimla High Court on 28 May, 2012. Resultantly, all the assets and liabilities of JHS Svendgaard Laboratories Limited (Transferor Company) and M/s. Waves Hygiene Products (Transferor Firm) was transferred to Company effective from 31 March, 2010, i.e. the Appointed Date. During 2017-18, M/s JHS Svendgaard Retail Ventures Pvt. Ltd. became the Subsidiary of the company with effect from April 13, 2018. JHS Svendgaard Brands Limited (formerly known as JHS Svendgaard Dental Care Limited) ceased to be Subsidiary of the Company w.e.f 01st September, 2020. During 2020-21, the Composite Scheme of Arrangement for Demerger of Retail Investment Division' (Demerged Undertaking) of JHS Svendgaard Laboratories Limited (Demerged Company) and vesting of the same with JHS Svendgaard Retail Ventures Private Limited (Resulting Company) on a going concern basis and immediately thereupon, amalgamation of JHS Svendgaard Brands Limited (Transferor Company) with JHS Svendgaard Laboratories Limited (Transferee Company) was approved on 09th October, 2020.

Managing Director

Nikhil Nanda.

Founded

2004

NSE Symbol

JHS

JHS Svendgaard Laboratories Ltd Management

NameDesignation
Nikhil Nanda.Managing Director
Mukul PathakIndependent Director
Rohina Sanjay SangtaniIndependent Director
Rajagopal ChakravarthiChairman & Independent Directo
Kapil MinochaIndependent Director
Vinay MittalNon Executive Director
KomalCompany Sec. & Compli. Officer
Upma ChawdhryIndependent Director

JHS Svendgaard Laboratories Ltd News

JHS Svendgaard Laboratories to discuss results
On 18 May 2024
JHS Svendgaard Laboratories to discuss results
On 14 February 2024
JHS Svendgaard Laboratories reports consolidated net loss of Rs 0.73 crore in the September 2023 quarter
Sales decline 10.07% to Rs 18.93 crore
JHS Svendgaard Laboratories to conduct board meeting
On 7 November 2023
JHS Svendgaard Laboratories AGM scheduled
On 28 September 2023
JHS Svendgaard fixes record date for composite scheme of arrangement
Record date is 11 September 2023
JHS Svendgaard Laboratories reports consolidated net loss of Rs 2.74 crore in the June 2023 quarter
Sales decline 10.70% to Rs 19.03 crore
JHS Svendgaard Laboratories to announce Quarterly Result
On 14 August 2023
JHS Svendgaard Laboratories reports consolidated net loss of Rs 9.87 crore in the March 2023 quarter
Sales rise 32.91% to Rs 25.40 crore
JHS Svendgaard Laboratories to announce Quarterly Result
On 30 May 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
HINDUNILVR₹ 5,55,102 Cr
₹ 2,362.55
(1.59 %)
54.40
NESTLEIND₹ 2,44,240 Cr
₹ 2,533.20
(0.79 %)
76.59
VBL₹ 1,90,141 Cr
₹ 1,463.30
(1.26 %)
103.78
GODREJCP₹ 1,35,109 Cr
₹ 1,320.95
(-0.75 %)
110.08
BRITANNIA₹ 1,22,043 Cr
₹ 5,066.80
(-0.07 %)
58.58

JHS Svendgaard Laboratories Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase JHS Svendgaard Laboratories Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. JHS Svendgaard Laboratories Ltd's share price is ₹16.45 as of May 10, 2024

JHS Svendgaard Laboratories Ltd's P/E ratio is 25.94 times as of May 10, 2024.

JHS Svendgaard Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 0.81, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. JHS Svendgaard Laboratories Ltd's market is 138 Cr as on May 10, 2024.

The current financial records of JHS Svendgaard Laboratories Ltd show a 1.49% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a JHS Svendgaard Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. JHS Svendgaard Laboratories Ltd's 52-week high and low as of May 10, 2024 are ₹16.65 and ₹16.35 respectively.

As of the Mar 2024 quarter, the promoter shareholding in JHS Svendgaard Laboratories Ltd stands at 37.73%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 0.00% to 2.30%.